ArticleBMJ paediatrics open2026

Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease.

Adi Eindor-Abarbanel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.